Key result
The i-TOF smartphone-based neuromuscular monitoring device demonstrated comparable efficacy to the standard TOF WATCH SX, with no significant difference in mean TOF ratio at induction (94.1% vs 99.9%, p=0.09).
Why the study?
Neuromuscular block monitoring is recommended to improve surgical myorelaxation and reduce postoperative residual curarization, motivating evaluation of the efficacy of the wireless smartphone-connectable i-TOF device compared with TOF WATCH SX.
Does the i-TOF smartphone-based device provide comparable neuromuscular block monitoring to the standard TOF WATCH SX in patients undergoing general anesthesia?
Observational (n=53)
No
Does the i-TOF smartphone-based device provide comparable neuromuscular block monitoring to the standard TOF WATCH SX in patients undergoing general anesthesia?
The i-TOF wireless neuromuscular monitoring device demonstrates comparable efficacy to the standard TOF WATCH SX, offering a portable and smartphone-integrated alternative for clinical practice.
Offers preliminary support for smartphone neuromuscular monitoring; leaves open need for larger validation before clinical use.
Neuromuscular block monitoring is recommended by international guidelines to improve myorelaxation during surgery and reduce the risk of postoperative residual curarization. We conducted a pilot study to verify the efficacy of i-TOF, a wireless neuromuscular monitoring device connectable to a smartphone, comparing it with TOF WATCH SX. We enrolled 53 patients who underwent general anesthesia. For each patient, we recorded by both devices, in different time intervals, train-of-four (TOF) count/ratio after induction to general anesthesia (TI0-TI3) and during recovery (TR0-TR3). Moreover, post-tetanic count (PTC) was evaluated during deep neuromuscular block (TP0-TP2). We noticed no significant differences between the devices in recorded mean values of TOF ratio, TOF count, and PTC analyzed at time intervals for every phase of general anesthesia, although the i-TOF tends to an underestimation compared to TOF WATCH SX. For each patient, data sessions were successfully recorded by a smartphone. This aspect could be relevant for clinicians in order to have a stored proof of good clinical practice to be added on anesthesiologist records. By our results, i-TOF demonstrates a comparable efficacy to TOF WATCH SX, suggesting that it could be a proven alternative to standard devices for neuromuscular block monitoring. Further studies are needed to confirm our findings.
No takes yet. Share an insight, caveat, or question.
Schiavoni et al. (2020) conducted an observational in General anesthesia (n=53). i-TOF vs. TOF WATCH SX was evaluated on TOF ratio at induction (TI0) (p=0.09). The i-TOF smartphone-based neuromuscular monitoring device demonstrated comparable efficacy to the standard TOF WATCH SX, with no significant difference in mean TOF ratio at induction (94.1% vs 99.9%, p=0.09).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: